YM-254890

Known as: YM254890 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
051020032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A simplified analog (WU-07047) of the selective Gαq/11 inhibitor YM-254890 has been synthesized, and an initial probe of its… (More)
Is this relevant?
2009
2009
We examined thromboxane A(2) receptor (TP)-mediated transactivation of epidermal growth factor receptor (EGFR) through the… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Long-chain fatty acids amplify insulin secretion from the pancreatic beta-cell. The G-protein-coupled receptor GPR40 is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2006
2006
The protective effect of YM-254890, a specific Galphaq/11 inhibitor, on laurate-induced peripheral arterial disease in rats was… (More)
Is this relevant?
2006
2006
Coexpression of the MAS proto-oncogene with the angiotensin II type 1 (AT(1)) receptor in CHO-K1 cells has been reported to… (More)
Is this relevant?
2005
2005
The pharmacological properties of YM-254890, a specific G(alpha)q/11 inhibitor, on acute thrombosis and chronic neointima… (More)
Is this relevant?
2004
2004
The structure elucidation and biological activity of novel YM-254890 (1) analogues and semi-synthetic derivatives are described… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
YM-254890, which was isolated from the culture broth of Chromobacterium sp., inhibits ADP-induced platelet aggregation and has… (More)
Is this relevant?
2003
2003
A novel platelet aggregation inhibitor, YM-254890, was isolated from the culture broth of strain QS3666. This strain was isolated… (More)
Is this relevant?
2003
2003
We examined the antithrombotic and thrombolytic effects of the G(q/11) inhibitor YM-254890 in an electrically-induced carotid… (More)
Is this relevant?